United Therapeutics Insider Sold Shares Worth $5,145,537, According to a Recent SEC Filing

MT newswire2026/10/06 20:38

04:38 PM EDT, 10/06/2026 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on October 05, 2026, sold 9,500 shares in United Therapeutics (UTHR) for $5,145,537. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 668,728 common shares of the company, with 40,513 shares held directly and 628,215 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1082554/000110657826000157/xslF345X05/primarydocument.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Citrini Research releases report optimistic about the prospects of RWA tokenization

AiCoin•2026/10/17 15:15

SWIFT, Ripple (XRP) & BNP Paribas: Connecting The Dots

DailyCoin•2026/10/17 13:48

Did Satoshi Get Bitcoin Wrong? Claude's NSA Discovery Sparks Debate

BeInCrypto•2026/10/17 13:09

2 Banking Giants Make Major Crypto Moves as Schwab and Deutsche Bank Expand Into Digital Assets

Cryptopotato•2026/10/17 11:27